Liye Li
General Practice · Brooklyn, NYNPI 1538498639
Payments from drug & device makers
Across 173 payments — averaging $42.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$3K
- Bayer$552
- Boehringer Ingelheim$500
- AstraZeneca$420
- Amgen$338
- Merck$273
- plus $2K from 18 others
What the payments were for
- Consulting fees$1,54021%
- Food & beverage$5,81479%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 70 | $3,419 |
| Bayer | 19 | $552 |
| Boehringer Ingelheim | 5 | $500 |
| AstraZeneca | 6 | $420 |
| Amgen | 12 | $338 |
| Merck | 19 | $273 |
| Boston Scientific | 2 | $260 |
| GSK | 5 | $198 |
| AbbVie | 3 | $167 |
| Novo Nordisk | 3 | $149 |
| Abbott | 1 | $136 |
| Medtronic | 1 | $135 |
| Madrigal Pharmaceuticals | 1 | $130 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Exact Sciences | 3 | $113 |
| Kowa Pharmaceuticals America, Inc. | 5 | $95 |
| Globus Medical | 1 | $91 |
| Amarin Pharma, Inc. | 6 | $81 |
| Phadia US Inc. | 3 | $50 |
| Pfizer | 3 | $42 |
| Nestle Healthcare Nutrition Inc. | 1 | $26 |
| Hologic Sales And Service, LLC | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,354 in reported general payments places this provider in the 95th percentile of 5,764 general practice providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VascepaIcosapent Ethyl | 678 | $242,104 |
| Diclofenac Epolamine | 238 | $139,467 |
| JanuviaSitagliptin Phosphate | 121 | $92,128 |
| Omeprazole-Sodium BicarbonateOmeprazole/Sodium Bicarbonate | 70 | $70,156 |
| JardianceEmpagliflozin | 59 | $47,360 |
| CreonLipase/Protease/Amylase | 78 | $46,374 |
| Diclofenac Sodium | 125 | $44,181 |
| VemlidyTenofovir Alafenamide | 28 | $39,798 |
| FarxigaDapagliflozin Propanediol | 46 | $39,790 |
| RybelsusSemaglutide | 28 | $29,491 |
| Lactulose | 14 | $19,771 |
| Clemastine Fumarate | 17 | $17,617 |
| JanumetSitagliptin Phos/Metformin Hcl | 18 | $12,996 |
| RestasisCyclosporine | 18 | $12,624 |
| EliquisApixaban | 22 | $12,368 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia, Janumet | $273 | $105,124139 claims |
| AbbVieCreon, Restasis, Linzess | $167 | $70,442112 claims |
| Boehringer IngelheimJardiance | $500 | $47,36059 claims |
| AstraZenecaFarxiga, Nexium | $420 | $42,97458 claims |
| GileadVemlidy | $3,419 | $39,79828 claims |
| Novo NordiskRybelsus | $149 | $29,49128 claims |
| PfizerEliquis | $42 | $12,36822 claims |
| GSKTrelegy Ellipta, Arexvy | $198 | $10,88625 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,764 general practice providers in New York.
Other general practice in Brooklyn
- Stuart DitchekBrooklyn$171K
- Anthony RamirezBrooklyn$114K
- Isaac TawilBrooklyn$60K
- Jerome CantorBrooklyn$32K
- Margarita DegtyarevaBrooklyn$14K
- Mark HochmanHicksville$5.1M
- Sarah AtkinsonRochester$4.2M
- Michael MashaalRoslyn$1.9M
- David RiceEast Amherst$1.2M
- Alejandra Gonzalez-DuarteNew York$519K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.